Expression of PINK1 in the brain, eye and ear of mouse during embryonic development

Journal of Chemical Neuroanatomy

Volumn 41, Issue 2, 2011, Pages 73-85

  d'Amora, Marta ^a   Angelini, Cristiano ^a   Marcoli, Manuela ^a   Cervetto, Chiara ^a   Kitada, Tohru ^b   Vallarino, Mauro ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Brain; Immunohistochemistry; Mouse embryos; PINK1; Western blot

Indexed keywords

AMINO ACID; PROTEIN PINK1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN THIRD VENTRICLE; BRAIN TISSUE; EAR; EMBRYO DEVELOPMENT; EYE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MESENCEPHALON; NEOCORTEX; NONHUMAN; PONS ANGLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHOMBENCEPHALON; TEGMENTUM; WESTERN BLOTTING;

ANIMALS; CORNEA; DIENCEPHALON; EMBRYONIC DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; LENS, CRYSTALLINE; MALE; MESENCEPHALON; MICE; NEURONS; ORGAN SPECIFICITY; PROTEIN ISOFORMS; PROTEIN KINASES; RHOMBENCEPHALON; SACCULE AND UTRICLE; SEMICIRCULAR CANALS;

EID: 79551545935     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2010.11.004     Document Type: Article

References (32)

1. Anichtchik O., Diekmann H., Fleming A., Roach A., Goldsmith P., Rubinsztein D.C. Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J. Neurosci. 2008, 28:8199-8207.
2. Beilina A., Van Der Brug M., Ahmad R., Kesavapany S., Miller D.W., Petsko G.A., Cookson M.R. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:5703-5708.
3. Blackinton J.G., Anvret A., Beilina A., Olson L., Cookson M.R., Galter D. Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease. Brain Res. 2007, 1184:10-16.
4. Clark I.E., Dodson M.W., Jiang C., Cao J.H., Huh J.R., Seol J.H., Yoo S.J., Hay B.A., Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006, 441:1162-1166.
5. Gandhi S., Muqit M.M., Stanyer L., Healy D.G., Abou-Sleiman P.M., Hargreaves I., Heales S., Ganguly M., Parsons L., Lees A.J., Latchman D.S., Holton J.L., Wood N.W., Revesz T. PINK1 protein in normal human brain and Parkinson's disease. Brain 2006, 129:1720-1731.
6. Haque M.E., Thomas K.J., D'Souza C., Callaghan S., Kitada T., Slack R.S., Fraser P., Cookson M.R., Tandon A., Park D.S. Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1716-1721.
7. Hatano Y., Li Y., Sato K., Asakawa S., Yamamura Y., Tomiyama H., Yoshino H., Asahina M., Kobayashi S., Hassin-Baer S., Lu C.S., Ng A.R., Rosales R.L., Shimizu N., Toda T., Mizuno Y., Hattori N. Novel PINK1 mutations in early-onset parkinsonism. Ann. Neurol. 2004, 56:424-427.
8. Ibáñez P., Lesage S., Lohmann E., Thobois S., De Michele G., Borg M., Agid Y., Dürr A., Brice A. Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. Brain 2006, 129:686-694.
9. Kaufmann M.H. Atlas of Mouse Development 2003, Academic Press, Elsevier.
10. Kitada T., Pisani A., Porter D.R., Yamaguchi H., Tscherter A., Martella G., Bonsi P., Zhang C., Pothos E.N., Shen J. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11441-11446.
11. Marongiu R., Spencer B., Crews L., Adame A., Patrick C., Trejo M., Dallapiccola B., Valente E.M., Masliah E. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J. Neurochem. 2009, 108:1561-1574.
12. Matsui H., Taniguchi Y., Inoue H., Kobayashi Y., Sakaki Y., Toyoda A., Uemura K., Kobayashi D., Takeda S., Takahashi R. Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement. Neurosci. Res. 2010, 66:151-161.
13. Mills R.D., Sim C.H., Mok S.S., Mulhern T.D., Culvenor J.G., Cheng H.C. Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J. Neurochem. 2008, 105:18-33.
14. Murakami T., Moriwaki Y., Kawarabayashi T., Nagai M., Ohta Y., Deguchi K., Kurata T., Morimoto N., Takehisa Y., Matsubara E., Ikeda M., Harigaya Y., Shoji M., Takahashi R., Abe K. PINK1, a gene product of PARK6, accumulates in alpha-synucleinopathy brains. J. Neurol. Neurosurg. Psychiatry 2007, 78:653-654.
15. Nakajima A., Kataoka K., Hong M., Sakaguchi M., Huh N.H. BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential. Cancer Lett. 2003, 201:195-201.
16. Park J., Lee S.B., Lee S., Kim Y., Song S., Kim S., Bae E., Kim J., Shong M., Kim J.M., Chung J. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006, 441:1157-1161.
17. Petit A., Kawarai T., Paitel E., Sanjo N., Maj M., Scheid M., Chen F., Gu Y., Hasegawa H., Salehi-Rad S., Wang L., Rogaeva E., Fraser P., Robinson B., St George-Hyslop P., Tandon A. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 2005, 280:34025-34032.
18. Petko J.A., Kabbani N., Frey C., Woll M., Hickey K., Craig M., Canfield V.A., Levenson R. Proteomic and functional analysis of NCS-1 binding proteins reveals novel signaling pathways required for inner ear development in zebrafish. BMC Neurosci. 2009, 10:27-42.
19. Poole A.C., Thomas R.E., Andrews L.A., McBride H.M., Whitworth A.J., Pallanck L.J. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1638-1643.
20. Pridgeon J.W., Olzmann J.A., Chin L.S., Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 2007, 5:e172.
21. Rice D., Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 2000, 108:511-533.
22. Silvestri L., Caputo V., Bellacchio E., Atorino L., Dallapiccola B., Valente E.M., Casari G. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 2005, 14:3477-3492.
23. Taymans J.M., Van den Haute C., Baekelandt V. Distribution of PINK1 and LRRK2 in rat and mouse brain. J. Neurochem. 2006, 98:951-961.
24. Todd A.M., Staveley B.E. Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease. Genome 2008, 51:1040-1046.
25. Unoki M., Nakamura Y. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 2001, 20:4457-4465.
26. Valente E., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., González-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
27. Valente E.M., Salvi S., Ialongo T., Marongiu R., Elia A.E., Caputo V., Romito L., Albanese A., Dalla piccola B., Bentivoglio A.R. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann. Neurol. 2004, 56:336-341.
28. Wang D., Qian L., Xiong H., Liu J., Neckameyer W.S., Oldham S., Xia K., Wang J., Bodmer R., Zhang Z. Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:13520-13525.
29. Wood-Kaczmar A., Gandhi S., Yao Z., Abramov A.Y., Miljan E.A., Keen G., Stanyer L., Hargreaves I., Klupsch K., Deas E., Downward J., Mansfield L., Jat P., Taylor J., Heales S., Duchen M.R., Latchman D., Tabrizi S.J., Wood N.W. PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One 2008, 3:e2455.
30. Yang Y., Wood N.W., Latchman D.S. Molecular basis of Parkinson's disease. Neuroreport 2009, 20:150-156.
31. Yang Y., Ouyang Y., Yang L., Beal M.F., McQuibban A., Vogel H., Lu B. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7070-7075.
32. Zhou H., Falkenburger B.H., Schulz J.B., Tieu K., Xu Z., Xia X.G. Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice. Int. J. Biol. Sci. 2007, 3:242-250.